Trial intelligence / Profile preview

Volume vs Concentration in Quadratus Lumborum Blocks for Nephrectomy

NCT04077398Phase 4Withdrawn

Start
Jan 2020
Primary completion
Jan 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms). Primary endpoint: Visual Analogue Scale for Pain at 72 hours. Planned start Jan 2020; status: withdrawn.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT04077398.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04077398.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call